Pre-Storage Leucodepletion Process for Blood Products
Pre-storage leucodepletion is performed by removing white blood cells from whole blood or blood components immediately after collection and before storage, typically using specialized filtration systems that are integrated into blood collection bags.
Methods of Leucodepletion
- Pre-storage leucodepletion is the standard practice in many countries, including the United States, as it provides more consistent quality control compared to bedside filtration 1
- The process involves filtering whole blood through specialized leukocyte reduction filters either immediately after collection or within hours of collection 2
- Two main approaches exist:
Technical Process
- Blood is collected into specialized blood bag systems that incorporate integral leukocyte filters 4
- For whole blood filtration:
- After filtration, the leucodepleted blood can be separated into components (red cells, plasma, platelets) 3
- The entire process should be performed under controlled conditions according to validated methods meeting Good Manufacturing Practice (GMP) standards 5
Efficiency and Quality Control
- Effective pre-storage leucodepletion removes >99.9% of white blood cells (>3 log reduction) 4
- Quality standards typically require:
- The filtration process may result in some platelet loss (up to 25-35%) which should be accounted for in transfusion planning 1
Benefits of Pre-Storage vs. Bedside Leucodepletion
- Pre-storage leucodepletion offers several advantages over bedside filtration:
Clinical Applications
- Pre-storage leucodepletion is particularly important for:
Common Pitfalls and Considerations
- Variables that can affect filtration efficiency include:
- Pre-storage leucodepletion has made additional filtration at the bedside unnecessary when using allogeneic blood products 2
- For cell salvage procedures, a 40-μm filter may still be indicated if small bone fragments contaminate the surgical field 2
- When administering platelets, it's important to use a clean giving set, as one previously used for red cells may cause platelets to adhere to residual red cells, reducing transfusion efficacy 2